Teitur Trophics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series B
  • (In Progress)

  • Investors
  • 9

Teitur Trophics General Information

Description

Operator of medical research company intended to study small peptides involved in neurogenerative diseases. The company's research studies receptors that are central to neural function and by understanding the biology of the receptor they can modulate key mechanisms in the neural function, enabling healthcare experts to develop treatments that through daily injections can prevent the development of diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Palle Juul-Jensens Boulevard 82
  • Region Midtjylland North
  • 8200 Aarhus
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Palle Juul-Jensens Boulevard 82
  • Region Midtjylland North
  • 8200 Aarhus
  • Denmark

Teitur Trophics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Teitur Trophics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 10-Sep-2026 In Progress Clinical Trials - Phase 1
7. Early Stage VC (Series A) 14-Mar-2023 Completed Clinical Trials - Phase 1
6. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
5. Early Stage VC 06-Dec-2021 Completed Pre-Clinical Trials
4. Accelerator/Incubator 02-Apr-2020 Completed Pre-Clinical Trials
3. Debt - General 01-Jan-2020 Completed Startup
2. Accelerator/Incubator 01-Jan-2020 Completed Startup
1. University Spin-Out 01-Jan-2020 Completed Startup
To view Teitur Trophics’s complete valuation and funding history, request access »

Teitur Trophics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 50,261 $158.67 $158.67 1x $158.67 21.43%
Ordinary 3,558 $126.95 $126.95 1x $126.95 1.52%
To view Teitur Trophics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Teitur Trophics Patents

Teitur Trophics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025037011-A2 Novel uses Inactive 16-Aug-2023
AU-2024324156-A1 Peptides for the treatment of disorders of the inner ear or the mastoic process Pending 16-Aug-2023
EP-4761747-A2 Peptides for the treatment of disorders of the inner ear or the mastoic process Pending 16-Aug-2023
WO-2025037011-A3 Peptides for the treatment of disorders of the inner ear or the mastoic process Inactive 16-Aug-2023
AU-2023218551-A1 Novel peptides Pending 09-Feb-2022 C07K7/06
To view Teitur Trophics’s complete patent history, request access »

Teitur Trophics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Teitur Trophics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Industrifonden Venture Capital Minority
Innovestor Venture Capital Minority
P53 Venture Capital Minority
Sound Bioventures Venture Capital Minority
Sunstone Life Science Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Teitur Trophics FAQs

  • When was Teitur Trophics founded?

    Teitur Trophics was founded in 2020.

  • Where is Teitur Trophics headquartered?

    Teitur Trophics is headquartered in Aarhus, Denmark.

  • What is the size of Teitur Trophics?

    Teitur Trophics has 14 total employees.

  • What industry is Teitur Trophics in?

    Teitur Trophics’s primary industry is Drug Discovery.

  • Is Teitur Trophics a private or public company?

    Teitur Trophics is a Private company.

  • What is Teitur Trophics’s current revenue?

    The current revenue for Teitur Trophics is .

  • How much funding has Teitur Trophics raised over time?

    Teitur Trophics has raised $32.3M.

  • Who are Teitur Trophics’s investors?

    Industrifonden, Innovestor, P53, Sound Bioventures, and Sunstone Life Science Ventures are 5 of 9 investors who have invested in Teitur Trophics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process